Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 Biomarker disease BEFREE Taken together, these results define novel APRIL actions via TACI on Tregs and Bregs to promote MM cell survival, providing the rationale for targeting APRIL/TACI system to alleviate the immunosuppressive BM milieu and improve patient outcome in MM. 30135465 2019
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 GeneticVariation disease GWASCAT Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. 27363682 2016
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 GeneticVariation disease GWASCAT Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. 23955597 2013
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 GeneticVariation disease GWASDB Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. 23955597 2013
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 Biomarker disease CTD_human Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. 23955597 2013
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 AlteredExpression disease BEFREE The aim of this study was to further characterize the role of TACI expression in MM DESIGN AND METHODS: Using gene expression profiling, we investigated whether these patterns are kept in TACI+ or TACI- HMCL. 17550853 2007
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 GeneticVariation disease BEFREE FISH analyses of these patients identified one MM carrying a 3.8 Mb amplified region and two MMs with gains specifically involving the TACI locus. 17823926 2007
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 Biomarker disease BEFREE This set makes it possible to efficiently classify TACI(hi) and TACI(lo) MMCs in an independent cohort of 40 patients. 15827134 2005
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.450 AlteredExpression disease LHGDN Expression of BCMA, TACI, and BAFF-R by MM taken together with the ability of BLyS to support MM cell growth and survival has exciting implications because they may be potential therapeutic targets. 14512299 2004